163 related articles for article (PubMed ID: 26983743)
21. Molecular evolution of oral poliovirus vaccine strains during multiplication in humans and possible implications for global eradication of poliovirus.
Friedrich F
Acta Virol; 2000 Apr; 44(2):109-17. PubMed ID: 10989702
[TBL] [Abstract][Full Text] [Related]
22. Progress toward the global interruption of wild poliovirus type 2 transmission, 1999.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 1999 Aug; 48(33):736-8, 747. PubMed ID: 10503575
[TBL] [Abstract][Full Text] [Related]
23. Current status of the global eradication of poliomyelitis.
Tangermann RH; Aylward B; Birmingham M; Horner R; Olivé JM; Nkowane BM; Hull HF; Burton A
World Health Stat Q; 1997; 50(3-4):188-94. PubMed ID: 9477548
[TBL] [Abstract][Full Text] [Related]
24. Epidemiology of poliomyelitis--options and update.
Dutta A
Vaccine; 2008 Oct; 26(45):5767-73. PubMed ID: 18755232
[TBL] [Abstract][Full Text] [Related]
25. Reaching the last one per cent: progress and challenges in global polio eradication.
Kew O
Curr Opin Virol; 2012 Apr; 2(2):188-98. PubMed ID: 22482715
[TBL] [Abstract][Full Text] [Related]
26. [Worldwide eradication of poliomyelitis].
Rasch G; Schreier E; Kiehl W; Kurth R
Wien Klin Wochenschr; 2001 Oct; 113(20-21):839-45. PubMed ID: 11732120
[TBL] [Abstract][Full Text] [Related]
27. Vaccine-derived poliovirus (VDPV): Impact on poliomyelitis eradication.
Minor P
Vaccine; 2009 May; 27(20):2649-52. PubMed ID: 19428874
[TBL] [Abstract][Full Text] [Related]
28. Circulating vaccine-derived polioviruses: current state of knowledge.
Kew OM; Wright PF; Agol VI; Delpeyroux F; Shimizu H; Nathanson N; Pallansch MA
Bull World Health Organ; 2004 Jan; 82(1):16-23. PubMed ID: 15106296
[TBL] [Abstract][Full Text] [Related]
29. Circulating vaccine derived polio viruses and their impact on global polio eradication.
Wagner BG; Earn DJ
Bull Math Biol; 2008 Jan; 70(1):253-80. PubMed ID: 17934778
[TBL] [Abstract][Full Text] [Related]
30. Imported vaccine-associated paralytic poliomyelitis--United States, 2005.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2006 Feb; 55(4):97-9. PubMed ID: 16456525
[TBL] [Abstract][Full Text] [Related]
31. [Circulating vaccine-derived poliovirus type 2 outbreak in Democratic Republic of Congo 2011-2012].
Bazira L; Coulibaly T; Mayenga M; Ncharre C; Yogolelo R; Mbule A; Moudzeo H; Lwamba P; Mulumba AW; Cabore J
Bull Soc Pathol Exot; 2015 Oct; 108(4):235-41. PubMed ID: 26288132
[TBL] [Abstract][Full Text] [Related]
32. Progress in the development of poliovirus antiviral agents and their essential role in reducing risks that threaten eradication.
McKinlay MA; Collett MS; Hincks JR; Oberste MS; Pallansch MA; Okayasu H; Sutter RW; Modlin JF; Dowdle WR
J Infect Dis; 2014 Nov; 210 Suppl 1():S447-53. PubMed ID: 25316866
[TBL] [Abstract][Full Text] [Related]
33. Inhibitory effects of 3-imino-5-phenyl-3H-1,2-dithiole on poliovirus type 1 replication in vitro.
Garozzo A; Pinizzotto MR; Furneri PM; Baratta D; Guerrera F; Castro A; Tornetta B; Geremia E
Antiviral Res; 1990; 14(4-5):267-77. PubMed ID: 1965112
[TBL] [Abstract][Full Text] [Related]
34. Identification and control of a poliomyelitis outbreak in Xinjiang, China.
Luo HM; Zhang Y; Wang XQ; Yu WZ; Wen N; Yan DM; Wang HQ; Wushouer F; Wang HB; Xu AQ; Zheng JS; Li DX; Cui H; Wang JP; Zhu SL; Feng ZJ; Cui FQ; Ning J; Hao LX; Fan CX; Ning GJ; Yu HJ; Wang SW; Liu DW; Wang DY; Fu JP; Gou AL; Zhang GM; Huang GH; Chen YS; Mi SS; Liu YM; Yin DP; Zhu H; Fan XC; Li XL; Ji YX; Li KL; Tang HS; Xu WB; Wang Y; Yang WZ
N Engl J Med; 2013 Nov; 369(21):1981-90. PubMed ID: 24256377
[TBL] [Abstract][Full Text] [Related]
35. Polio endgame. Wanted: drug for a disappearing disease.
Enserink M
Science; 2004 Mar; 303(5666):1971. PubMed ID: 15044783
[No Abstract] [Full Text] [Related]
36. Update on vaccine-derived polioviruses--worldwide, April 2011-June 2012.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2012 Sep; 61():741-6. PubMed ID: 22992572
[TBL] [Abstract][Full Text] [Related]
37. [VACCINE-ASSOCIATED PARALYTIC POLIOMYELITIS IN RUSSIAN FEDERATION DURING THE PERIOD OF CHANGES IN VACCINATION SCHEDULE (2006-2013 yy.)].
Ivanova OE; Eremeeva TP; Morozova NS; Shakaryan AK; Gmyl AP; Yakovenko ML; Korotkova EA; Chernjavskaja OP; Baykova OY; Silenova OV; Krasota AY; Krasnoproshina LI; Mustafina AN; Kozlovskaja LI
Vopr Virusol; 2016; 61(1):9-15. PubMed ID: 27145594
[TBL] [Abstract][Full Text] [Related]
38. Poliovirus infection without accumulation of eclipse particles.
Ofori-Anyinam O; Vrijsen R; Kronenberger P; Boeyé A
Antiviral Res; 1995 Jan; 26(1):27-35. PubMed ID: 7741519
[TBL] [Abstract][Full Text] [Related]
39. Global Polio Eradication Initiative Strategic Plan, 2004.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2004 Feb; 53(5):107-8. PubMed ID: 14961005
[TBL] [Abstract][Full Text] [Related]
40. Decision analysis in planning for a polio outbreak in the United States.
Jenkins PC; Modlin JF
Pediatrics; 2006 Aug; 118(2):611-8. PubMed ID: 16882814
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
